Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 24.89

+1.0%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (1073)	11/19/1998 3:33:00 PM
From: Judy	Read Replies (4) of 1722

Anthony, IMNX has announced that sales of Enbrel will be more than the Street estimated. Stock was up 11 points last I looked. I am confident that HMOs and insurance companies will bear the cost of Enbrel for patients. RA is a crippling and debilitating disease, the cost of Enbrel would be less than the treatment/maintenance expenses for a incapacitated person for their lifetime. Enbrel is necessary for patient survival ... not like Viagra which has more to do with the quality of life.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next